Martek Biosciences (NASDAQ: MATK) reported Thursday that the company will acquire Amerifit Brands Inc. for $200 million, according to Associated Press.
Charterhouse Group Inc. is selling Amerifit in an all-cash deal to Martek, who will pay $120 million from its cash reserves and use a new credit facility to fund the rest.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Amerifit Brands Inc. is a health and wellness company that makes Culturelle, a probiotic supplement, and Estroven, a nutritional supplement used to treat symptoms of menopause.
The acquisition, which should close during Martek's second quarter, is expected to add to the company's earnings in fiscal 2010.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
